PEREZ, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 3.301
EU - Europa 2.133
AS - Asia 885
SA - Sud America 59
AF - Africa 44
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.464
Nazione #
US - Stati Uniti d'America 3.209
IT - Italia 569
FR - Francia 418
DE - Germania 408
CN - Cina 396
NL - Olanda 210
GB - Regno Unito 126
IN - India 93
CA - Canada 72
RO - Romania 69
HK - Hong Kong 65
JP - Giappone 59
SE - Svezia 56
KR - Corea 38
ES - Italia 36
CZ - Repubblica Ceca 34
RU - Federazione Russa 34
TW - Taiwan 34
ID - Indonesia 30
AU - Australia 27
IR - Iran 26
UA - Ucraina 26
IE - Irlanda 21
CH - Svizzera 18
GR - Grecia 18
TR - Turchia 18
BR - Brasile 17
TH - Thailandia 16
FI - Finlandia 15
SG - Singapore 15
ZA - Sudafrica 14
IL - Israele 13
MX - Messico 13
NZ - Nuova Zelanda 12
PH - Filippine 12
PL - Polonia 12
PK - Pakistan 11
AR - Argentina 10
CL - Cile 10
CO - Colombia 10
IQ - Iraq 10
PE - Perù 10
VN - Vietnam 10
BG - Bulgaria 9
LT - Lituania 8
MA - Marocco 8
MY - Malesia 8
NO - Norvegia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CY - Cipro 6
DK - Danimarca 6
MK - Macedonia 6
AT - Austria 4
EG - Egitto 4
MT - Malta 4
SD - Sudan 4
GH - Ghana 3
JM - Giamaica 3
LB - Libano 3
PT - Portogallo 3
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
KE - Kenya 2
NG - Nigeria 2
SC - Seychelles 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
CM - Camerun 1
CU - Cuba 1
GE - Georgia 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SS - ???statistics.table.value.countryCode.SS??? 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.464
Città #
Fairfield 437
Houston 329
Ashburn 265
Woodbridge 211
Seattle 206
Palermo 179
Santa Cruz 158
Wilmington 151
Ann Arbor 140
Des Moines 139
Cambridge 136
Buffalo 118
Beijing 81
Wuhan 52
Rome 50
Shanghai 45
Chicago 33
Columbus 31
Nanjing 30
Toronto 30
University Park 30
Boardman 27
Hangzhou 27
Bengaluru 25
Milan 24
Mountain View 24
Central 22
San Diego 22
Nürnberg 21
New York 20
Ottawa 20
Taipei 20
Dublin 18
Las Vegas 18
Los Angeles 17
Dallas 15
Guangzhou 15
Phoenix 13
Clearwater 12
Muizenberg 12
Changsha 11
Helsinki 10
Jakarta 10
Singapore 10
Bandung 9
Chengdu 9
Fremont 9
Henderson 9
Leawood 9
Milpitas 9
Naples 9
Tianjin 9
Amsterdam 8
Hong Kong 8
Kashiwa 8
San Jose 8
Scranton 8
Sydney 8
Tokyo 8
Basel 7
Bucharest 7
Central District 7
Dinslaken 7
Duncan 7
Easton 7
Lima 7
Monterrey 7
New Taipei 7
Ossining 7
Riva 7
Seoul 7
Shenyang 7
Athens 6
Bangalore 6
Fiumicino 6
Florence 6
Genoa 6
Lampertheim 6
Madrid 6
Mumbai 6
Málaga 6
North York 6
Pittsburgh 6
Port Coquitlam 6
Sofia 6
Atlanta 5
Bangkok 5
Bogotá 5
Bolzano 5
Boston 5
Catania 5
Chongqing 5
Dearborn 5
Delhi 5
Frankfurt am Main 5
Hanoi 5
Heidelberg 5
Limassol 5
London 5
Moscow 5
Totale 3.636
Nome #
Effects of Dietary Restriction on Cancer Development and Progression, file e3ad891b-d1f5-da0e-e053-3705fe0a2b96 818
Dietary restriction: could it be considered as speed bump on tumor progression road?, file e3ad8919-0b8f-da0e-e053-3705fe0a2b96 543
EGFR inhibition in NSCLC: New findings…. and opened questions?, file e3ad891a-e75e-da0e-e053-3705fe0a2b96 539
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs, file e3ad891b-60d9-da0e-e053-3705fe0a2b96 457
A headlight on liquid biopsies: a challenging tool for breast cancer management, file e3ad8919-1039-da0e-e053-3705fe0a2b96 394
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab, file e3ad891b-14a7-da0e-e053-3705fe0a2b96 394
Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity, file e3ad891b-7bcd-da0e-e053-3705fe0a2b96 364
Role and importance of polymorphisms with respect to DNA methylation for the expression of CYP2E1 enzyme, file e3ad8916-a144-da0e-e053-3705fe0a2b96 343
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option?, file e3ad8918-4793-da0e-e053-3705fe0a2b96 286
Liquid Biopsy in Breast Cancer, file e3ad891b-6794-da0e-e053-3705fe0a2b96 282
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC), file e3ad891b-3782-da0e-e053-3705fe0a2b96 207
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients, file e3ad891e-ce8b-da0e-e053-3705fe0a2b96 205
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines, file e3ad891b-2783-da0e-e053-3705fe0a2b96 199
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study, file e3ad8921-882c-da0e-e053-3705fe0a2b96 165
Association of circulating tumor DNA (ctDNA) mutations and circulating miRNAs variations, through liquid biopsy, in Non-Small Cell Lung Cancer (NSCLC) patients., file e3ad891c-2c7d-da0e-e053-3705fe0a2b96 146
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL, file e3ad8921-f5e8-da0e-e053-3705fe0a2b96 144
null, file e3ad891b-6cb8-da0e-e053-3705fe0a2b96 119
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors, file e3ad8921-cca5-da0e-e053-3705fe0a2b96 105
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway, file e3ad8919-4bd3-da0e-e053-3705fe0a2b96 98
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible, file b7ea5aad-4f2d-45b8-a0e9-b5e45cdf82c1 80
Methylation decrease of BECN1 gene induced by phytochemical Indicaxantin in Caco2 cells: an epigenetic hypothesis of autophagy, file e3ad8916-fabd-da0e-e053-3705fe0a2b96 79
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis, file bde11d1e-a3c7-4772-a073-473b4c78c72c 76
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials, file e3ad8927-4bd7-da0e-e053-3705fe0a2b96 70
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma, file e3ad8926-e916-da0e-e053-3705fe0a2b96 56
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS., file e3ad891b-493b-da0e-e053-3705fe0a2b96 51
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines, file e3ad891b-68c8-da0e-e053-3705fe0a2b96 47
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs), file e3ad8927-33ba-da0e-e053-3705fe0a2b96 45
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses, file e3ad8927-5707-da0e-e053-3705fe0a2b96 43
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients, file e3ad891b-2761-da0e-e053-3705fe0a2b96 42
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study, file 1606f643-b66b-4e9f-96d7-5908f5d2d3de 39
IL-1β maintains the DNA hypermethylation of anti-inflammatory IL-10 gene in a human intestinal epithelial cell line, file e3ad8916-fbb2-da0e-e053-3705fe0a2b96 39
LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR, file e3ad891c-1cb0-da0e-e053-3705fe0a2b96 39
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay, file 1bd24d10-3d45-4e73-a4c4-698c69ce8bbb 33
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers, file e3ad891a-81b7-da0e-e053-3705fe0a2b96 33
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors, file e1ff73b9-70c2-4089-bba2-b453fe3437b1 27
PROTACs: The Future of Leukemia Therapeutics, file 7cbca8dd-12f6-4d92-8120-41e7972d9d4f 24
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway, file e3ad8924-a00f-da0e-e053-3705fe0a2b96 18
Farmacogenética de la Tuberculosis: Nuevo modelo de predicción de hepatotoxicidad inducida por fármacos antituberculosis, file e3ad891b-6912-da0e-e053-3705fe0a2b96 16
Molecular analysis of Spheroids from Adipose-derived Stem Cells (S-ASCs) during in vitro long-term culture., file e3ad891b-86d9-da0e-e053-3705fe0a2b96 12
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study, file 5bcfcd30-ad66-4a32-9917-8b67260bf7b8 9
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells, file e3ad891d-4747-da0e-e053-3705fe0a2b96 9
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis, file e3ad8920-1335-da0e-e053-3705fe0a2b96 9
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab, file 06c2c8e0-8887-451c-b39a-83a92c787a67 6
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?, file c0815438-99c9-4c20-bf69-b93a9a81826b 5
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors?, file e3ad8922-a36c-da0e-e053-3705fe0a2b96 5
FEASIBILITY OF EGFR EVALUATION IN BLADDER WASHINGS OF PATIENTS AFFECTED BY NON MUSCLE-INVASIVE BLADDER CANCER., file e3ad8919-0f32-da0e-e053-3705fe0a2b96 4
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors, file e3ad8920-7432-da0e-e053-3705fe0a2b96 4
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications, file e3ad8920-ab2b-da0e-e053-3705fe0a2b96 3
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors, file e3ad8921-fc9c-da0e-e053-3705fe0a2b96 2
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?, file e3ad8928-796d-da0e-e053-3705fe0a2b96 2
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning, file e3ad8928-8d91-da0e-e053-3705fe0a2b96 2
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma, file e3ad8922-0df1-da0e-e053-3705fe0a2b96 1
Totale 6.738
Categoria #
all - tutte 14.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019195 0 0 0 0 0 0 0 0 0 0 99 96
2019/20201.236 74 60 129 258 107 100 105 82 108 79 78 56
2020/2021967 90 92 57 117 82 75 74 80 57 96 94 53
2021/20221.111 90 79 59 189 164 62 50 54 64 47 181 72
2022/2023848 22 39 147 150 43 72 157 51 20 45 86 16
2023/20241.047 54 61 82 84 117 52 147 326 34 46 44 0
Totale 6.738